Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Protagonist Therapeutics (PTGX) Receivables Refunds (2017 - 2022)

Historic Receivables Refunds for Protagonist Therapeutics (PTGX) over the last 6 years, with Q2 2022 value amounting to $2.6 million.

  • Protagonist Therapeutics' Receivables Refunds fell 467.96% to $2.6 million in Q2 2022 from the same period last year, while for Jun 2022 it was $2.6 million, marking a year-over-year decrease of 467.96%. This contributed to the annual value of $2.8 million for FY2021, which is 15756.46% up from last year.
  • Protagonist Therapeutics' Receivables Refunds amounted to $2.6 million in Q2 2022, which was down 467.96% from $2.9 million recorded in Q1 2022.
  • Protagonist Therapeutics' Receivables Refunds' 5-year high stood at $2.9 million during Q1 2022, with a 5-year trough of $153000.0 in Q1 2020.
  • In the last 5 years, Protagonist Therapeutics' Receivables Refunds had a median value of $1.8 million in 2021 and averaged $1.6 million.
  • In the last 5 years, Protagonist Therapeutics' Receivables Refunds tumbled by 9184.43% in 2020 and then surged by 109150.33% in 2021.
  • Over the past 5 years, Protagonist Therapeutics' Receivables Refunds (Quarter) stood at $1.4 million in 2018, then plummeted by 87.89% to $173000.0 in 2019, then surged by 526.59% to $1.1 million in 2020, then surged by 157.56% to $2.8 million in 2021, then dropped by 5.16% to $2.6 million in 2022.
  • Its last three reported values are $2.6 million in Q2 2022, $2.9 million for Q1 2022, and $2.8 million during Q4 2021.